Skip to main content
. 2024 Jun 19;13(12):3592. doi: 10.3390/jcm13123592

Figure 1.

Figure 1

Summary of patient outcome according to Kaplan–Meier method after treatment with CyberKnife SRS. (A) Local tumor control (LTC) rate, (B) overall survival (OS) rate, and (C) progression-free survival (PFS) rate of the adult (black, solid) and pediatric (blue, dash) series with recurrent medulloblastomas with number of lesions (A) and patients (B + C) at risk.